Liver Metastasis of Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Metastasis".
Deadline for manuscript submissions: closed (15 January 2024) | Viewed by 1205
Special Issue Editor
Interests: oncology; liquid biopsy; mechanism of liver metastases
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Liver metastases: the evolution of understanding the mechanisms, diagnosis and treatment options.
This Special Issue will focus on describing historically how our understanding of the mechanisms of disease has evolved and what future directions are needed. We will also describe the evolution of the diagnosis of the disease and how new technologies, such as liquid biopsies (ctDNA, CTCs, EVs) and biobanks, have advanced our ability to diagnose the disease and its recurrence, as well as to introduce new treatment options. In another chapter, we will explore different treatment options which have arisen over the years, from chemotherapy to targeted therapy and surgical interventions, and how both modalities have improved. We will also explore the impact on overall survival and progression-free survival with respect to quality of life and the direction of clinical trials.
All chapters in this Issue will focus on the impact different components have had on modeling clinical trials and their impact, the lesson learned, and the next steps.
Finally, the last chapter will encompass patients’ perspective on treatment options, understanding of the disease, and what is most important for them. For this, we will reach out to patient advocacy groups.
Dr. Anthoula Lazaris
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- liver metastases
- mechanism of metastases
- tumor and immune microenvironement
- liquid biopsies
- biobanks
- treatments (targeted therapies and surgical)
- patient advocacy
